| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 138, 1233-1242, Copyright © 1991 by American Society for Investigative Pathology
REGULAR ARTICLES |
A Schmitt-Graff, S Kruger, F Bochard, G Gabbiani and H Denk
Department of Pathology, University of Geneva, Switzerland.
It has been suggested that perisinusoidal liver cells (PSC) play a pivotal role in the pathogenesis of fibrocontractive changes. Using light and electron microscopic immunolocalization techniques, a series of 207 normal and pathologic human liver specimens were evaluated for the expression of alpha smooth muscle (SM) actin and desmin in this and other nonparenchymal cell types. In normal adult liver tissue, PSCs were practically devoid of desmin and exceptionally stained for alpha- SM actin, whereas this actin isoform frequently was encountered in PSCs from the embryonic to the adolescent period. A broad spectrum of pathologic conditions was accompanied by the presence of alpha-SM actin containing PSCs; these were detected preferentially in periportal or perivenular zones according to the predominant location of the underlying hepatocellular damage. The occurrence of this PSC phenotype generally was associated with fibrogenesis and was in some cases detected earlier than overt collagen accumulation. Fibrous bands subdividing liver tissue in cirrhosis and focal nodular hyperplasia, as well as desmoplastic reaction to malignant tumors, contained alpha-SM actin-rich cells admixed with variable proportions of cells coexpressing desmin. In end stages, this population was less numerous than in active fibrotic or cirrhotic processes. Using immunogold electron microscopy, alpha-SM actin was localized in microfilament bundles of typical PSCs. Our results are compatible with the assumption that the appearance of alpha-SM actin and desmin-expressing myofibroblasts results at least in part from a phenotypic modulation of PSCs.
This article has been cited by other articles:
![]() |
M. von Mehren, R. J. Schilder, J. D. Cheng, E. Temmer, T. M. Cardoso, F. G. Renshaw, E. Bayever, P. Zannikos, Z. Yuan, and R. B. Cohen A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignancies Ann. Onc., October 1, 2008; 19(10): 1802 - 1809. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Munoz-Luque, J. Ros, G. Fernandez-Varo, S. Tugues, M. Morales-Ruiz, C. E. Alvarez, S. L. Friedman, V. Arroyo, and W. Jimenez Regression of Fibrosis after Chronic Stimulation of Cannabinoid CB2 Receptor in Cirrhotic Rats J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 475 - 483. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Friedman Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver Physiol Rev, January 1, 2008; 88(1): 125 - 172. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tsujino, I. Seshimo, H. Yamamoto, C. Y. Ngan, K. Ezumi, I. Takemasa, M. Ikeda, M. Sekimoto, N. Matsuura, and M. Monden Stromal Myofibroblasts Predict Disease Recurrence for Colorectal Cancer Clin. Cancer Res., April 1, 2007; 13(7): 2082 - 2090. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. F. Si, J. Li, X. W. Lu, and Y. Jin Suppressive Effects of Leflunomide on Leptin-Induced Collagen I Production Involved in Hepatic Stellate Cell Proliferation Experimental Biology and Medicine, March 1, 2007; 232(3): 427 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Waltregny, L. de Leval, W. Glenisson, S. Ly Tran, B. J. North, A. Bellahcene, U. Weidle, E. Verdin, and V. Castronovo Expression of Histone Deacetylase 8, a Class I Histone Deacetylase, Is Restricted to Cells Showing Smooth Muscle Differentiation in Normal Human Tissues Am. J. Pathol., August 1, 2004; 165(2): 553 - 564. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Cao, K. M. Mak, C. Ren, and C. S. Lieber Leptin Stimulates Tissue Inhibitor of Metalloproteinase-1 in Human Hepatic Stellate Cells: RESPECTIVE ROLES OF THE JAK/STAT AND JAK-MEDIATED H2O2-DEPENDENT MAPK PATHWAYS J. Biol. Chem., February 6, 2004; 279(6): 4292 - 4304. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yamate, M. Maeda, S. J. Benn, J. E. Laithwaite, A. Allan, M. Ide, M. Kuwamura, T. Kotani, S. Sakuma, and J. Lamarre Differential Effects of Transforming Growth Factor-{beta}1, a Fibrogenic Factor, on Macrophage-Like Cells (HS-P) and Myofibroblastic Cells (MT-9) In Vitro Toxicol Pathol, June 1, 2001; 29(4): 483 - 491. [Abstract] [PDF] |
||||
![]() |
D. Cassiman, J. van Pelt, R. De Vos, F. Van Lommel, V. Desmet, S.-H. Yap, and T. Roskams Synaptophysin: A Novel Marker for Human and Rat Hepatic Stellate Cells Am. J. Pathol., December 1, 1999; 155(6): 1831 - 1839. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mallat, C. Gallois, J. Tao, A. Habib, J. Maclouf, P. Mavier, A.-M. Preaux, and S. Lotersztajn Platelet-derived Growth Factor-BB and Thrombin Generate Positive and Negative Signals for Human Hepatic Stellate Cell Proliferation. ROLE OF A PROSTAGLANDIN/CYCLIC AMP PATHWAY AND CROSS-TALK WITH ENDOTHELIN RECEPTORS J. Biol. Chem., October 16, 1998; 273(42): 27300 - 27305. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gallois, A. Habib, J. Tao, S. Moulin, J. Maclouf, A. Mallat, and S. Lotersztajn Role of NF-kappa B in the Antiproliferative Effect of Endothelin-1 and Tumor Necrosis Factor-alpha in Human Hepatic Stellate Cells. INVOLVEMENT OF CYCLOOXYGENASE-2 J. Biol. Chem., September 4, 1998; 273(36): 23183 - 23190. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Ramm, V. G. Nair, K. R. Bridle, R. W. Shepherd, and D. H. G. Crawford Contribution of Hepatic Parenchymal and Nonparenchymal Cells to Hepatic Fibrogenesis in Biliary Atresia Am. J. Pathol., August 1, 1998; 153(2): 527 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gabbiani Evolution and clinical implications of the myofibroblast concept Cardiovasc Res, June 1, 1998; 38(3): 545 - 548. [Full Text] [PDF] |
||||
![]() |
R. S. Blank, E. A. Swartz, M. M. Thompson, E. N. Olson, and G. K. Owens A Retinoic Acid–Induced Clonal Cell Line Derived From Multipotential P19 Embryonal Carcinoma Cells Expresses Smooth Muscle Characteristics Circ. Res., May 1, 1995; 76(5): 742 - 749. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |